ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1145

Numerically Reduced but MSU Crystal-Activated NK Cells Promote Osteoclastogenesis in Gout

Ki-Jeong Park1, Young-Nan Cho2, Hye-Mi Jin2, Hye-Min Jeong2, Sung-Eun Choi3, Ji-Hyoun Kang1, Dong-Jin Park1, Tae-jong Kim4, Shin-Seok Lee5 and Yong-Wook Park6, 1Chonnam National University Hospital, Gwangju, Republic of Korea, 2Chonnam National University Medical School, Gwangju, Republic of Korea, 3Chonnam National University Medical School & Hospital, Gwangju, Republic of Korea, 4Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwang-Ju, South Korea, 5Chonnam National University Medical School and Hospital, Gwangju, Republic of Korea, 6Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea

Meeting: ACR Convergence 2025

Keywords: gout, innate immunity, Natural Killer Cells, osteoclastogenesis, RANKL

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1123–1146) Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Gout is an inflammatory arthritis characterized by acute attacks, tophi formation, and bone destruction triggered by inflammatory responses to monosodium urate (MSU) crystals. Natural killer (NK) cells are key effectors of the innate immune system that recognize damage-associated molecular patterns (DAMPs) to initiate and amplify inflammatory responses. While MSU crystals deposited in the synovium may act as DAMPs and potentially activate NK cells, the role of these cells in gout pathophysiology remains unclear.

Methods: Peripheral blood and synovial fluid samples were collected from patients with gout and healthy controls (HCs). Flow cytometry was performed to analyze NK cells for their activation markers (CD69, PD-1, TIM-3), apoptosis (Annexin V), and cytokine/chemokine expression (IFN-γ, TNF-α, CCR2, CCR6, CXCR3, and CXCR4). NK cells were stimulated with MSU crystals and sorted by FACS sorter, while monocytes were isolated from PBMC using MACS. To evaluate osteoclastogenesis, MSU-stimulated NK cells and monocytes were cocultured in the presence of M-CSF, followed by TRAP staining. The expression of RANKL in MSU-stimulated NK cells was assessed using both flow cytometry and RT-PCR.

Results: The frequency of NK cells was decreased in the peripheral blood of gout patients, with intercritical stage patients showing a statistically significant reduction compared to HCs. These NK cells exhibited elevated annexin V expression, indicating late-stage apoptosis. Under PMA-IM stimulation, NK cells from both gout patients and HCs produced comparable levels of IFN-γ and TNF-α. In synovial fluid, the frequency of NK cells was significantly lower than in peripheral blood, but their CD69 and annexin V expression levels were higher. Chemokine receptor expression, including CCR2, CCR6, CXCR3, and CXCR4, tend to be elevated in synovial fluid-derived NK cells. Furthermore, NK cells stimulated with MSU crystals demonstrated increased CD69 and annexin V expression, suggesting activation by MSU. Notably, MSU-activated NK cells promoted osteoclastogenesis in both direct and indirect manners, as shown in co-culture experiments with or without transwell systems. These cells also exhibited elevated RANKL expression, confirmed by both flow cytometry and RT-PCR.

Conclusion: NK cells are numerically reduced and may undergo late-stage apoptosis in the peripheral blood of gout patients. In synovial fluid, NK cells show elevated expression of activation markers and chemokine receptors despite their decreased numbers, suggesting their apoptosis or migration from peripheral tissues to the synovium. MSU crystals activate NK cells, which in turn promote osteoclastogenesis, partly through increased RANKL expression. These findings suggest that NK cells play a key role in amplifying synovial inflammation and contributing to bone destruction in gout.

Supporting image 1MSU-activated NK cells can induce osteoclastogenesis and express RANKL

(A) Scheme of the experiment (B-C) TRAP stain of MSU-Activated NK cells (D-E) Representative gating and Frequency of RANKL in CD56dim and CD56bright NK cells with or without MSU crystal using flow cytometry (F) RANKL expression of NK cells with or without MSU crystal in RT-PCR


Disclosures: K. Park: None; Y. Cho: None; H. Jin: None; H. Jeong: None; S. Choi: None; J. Kang: None; D. Park: None; T. Kim: None; S. Lee: None; Y. Park: None.

To cite this abstract in AMA style:

Park K, Cho Y, Jin H, Jeong H, Choi S, Kang J, Park D, Kim T, Lee S, Park Y. Numerically Reduced but MSU Crystal-Activated NK Cells Promote Osteoclastogenesis in Gout [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/numerically-reduced-but-msu-crystal-activated-nk-cells-promote-osteoclastogenesis-in-gout/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/numerically-reduced-but-msu-crystal-activated-nk-cells-promote-osteoclastogenesis-in-gout/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology